262 related articles for article (PubMed ID: 6243332)
1. T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.
Leclerc JC; Cantor H
J Immunol; 1980 Feb; 124(2):846-50. PubMed ID: 6243332
[TBL] [Abstract][Full Text] [Related]
2. T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo.
Leclerc JC; Cantor H
J Immunol; 1980 Feb; 124(2):851-4. PubMed ID: 6243333
[TBL] [Abstract][Full Text] [Related]
3. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
4. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
Plata F; Jongeneel V; Cerottini JC; Brunner KT
Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
[TBL] [Abstract][Full Text] [Related]
5. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
Plata F; Cerottini JC; Brunner KT
Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
[TBL] [Abstract][Full Text] [Related]
6. T cell-mediated immunity to oncornavirus-induced tumors. IV. Preliminary evidence for a specific suppression of anti-Moloney cell-mediated immune response by autoimmune T cells.
Leclerc JC; Plater C; Connan F; Debré P
Eur J Immunol; 1981 Jan; 11(1):45-7. PubMed ID: 6452279
[TBL] [Abstract][Full Text] [Related]
7. Suppressor T cells regulate the cytolytic T lymphocyte response to syngeneic tumors induced by murine sarcoma virus (MSV) in the mouse.
Plata F; MacDonald HR; Shain B
J Immunol; 1979 Aug; 123(2):852-60. PubMed ID: 156765
[TBL] [Abstract][Full Text] [Related]
8. Characterization of effector lymphocytes associated with immunity to murine sarcoma virus (MSV) induced tumors. I. Physical properties of cytolytic T lymphocytes generated in vitro and of their immediate progenitors.
Plata R; MacDonald HR; Engers HD
J Immunol; 1976 Jul; 117(1):52-8. PubMed ID: 180182
[TBL] [Abstract][Full Text] [Related]
9. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice.
Plater C; Debré P; Leclerc JC
Eur J Immunol; 1981 Jan; 11(1):39-44. PubMed ID: 6452278
[TBL] [Abstract][Full Text] [Related]
10. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
Plata F; Jongeneel CV
J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
[No Abstract] [Full Text] [Related]
11. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
[No Abstract] [Full Text] [Related]
12. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
Ryser JE; Cerottini JC; Brunner KT
Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
[TBL] [Abstract][Full Text] [Related]
13. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.
Zanovello P; Vallerani E; Biasi G; Landolfo S; Collavo D
J Immunol; 1988 Feb; 140(4):1341-4. PubMed ID: 2830339
[TBL] [Abstract][Full Text] [Related]
15. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells.
Brunner KT; MacDonald HR; Cerottini JC
J Immunol; 1980 Apr; 124(4):1627-34. PubMed ID: 6154076
[No Abstract] [Full Text] [Related]
16. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.
Biasi G; Facchinetti A; Panozzo M; Zanovello P; Chieco-Bianchi L; Collavo D
J Immunol; 1991 Oct; 147(7):2284-9. PubMed ID: 1833453
[TBL] [Abstract][Full Text] [Related]
17. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
[TBL] [Abstract][Full Text] [Related]
18. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
[TBL] [Abstract][Full Text] [Related]
19. [Functional activity of cytolytic T lymphocytes in the rejection of tumor target cells].
Brunner KT; Cerottini JC
Ann Immunol (Paris); 1977; 128(1-2):473-83. PubMed ID: 139840
[TBL] [Abstract][Full Text] [Related]
20. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]